Stempeutics partners with Cipla diabetic foot ulcer treatment product

Stempeutics partners with Cipla for diabetic foot ulcer treatment product

11:08 AM, 18th September 2019
Stempeutics Research logo

NEW DELHI, INDIA: Biotech firm Stempeutics Research has signed an out-licensing deal with pharma major Cipla for novel stem cell product 'Stempeucel-DFU' for treating non-healing diabetic foot ulcer.

The deal consists of upfront payment and various milestones-based payments, Stempeutics Research said in a statement.

Under the agreement, Cipla will get exclusive marketing rights for five years in India for the diabetic foot ulcer (DFU) product. Stempeutics will manufacture and supply the product to Indian company, it added.

The company, however, did not provide any financial details of the agreement.

The availability of the product in India is expected from the beginning of 2021, after undergoing the Phase 3 clinical trial here, which is expected to begin from October 2019, Stempeutics Research said.

"We are pleased to partner with Stempeutics in bringing the next generation of biologics to address unmet medical needs in India. DFU is a serious condition that requires immediate treatment to re-establish blood-flow to the affected area to prevent leg from amputation," Cipla India Business Head Nikhil Chopra said.

Stempeucel-DFU offers a novel treatment approach to the physicians in India to treat DFU and, will substantially improve the quality of life of thousands of patients suffering from this painful disease, he added.

Commenting on the development, Stempeutics CEO BN Manohar said: "We are extremely happy to collaborate with Cipla in developing cell therapy product for non-healing DFU."

Manipal Education and Medical Group (MEMG) Group firm Stempeutics is an advanced clinical stage bio-tech company.

Source: PTI

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Evonik breaks ground on new polyamide 12 complex in Marl, Germany

ESSEN/MARL, GERMANY: Evonik has officially begun construction on its largest investment to date in Germany. The company is expanding capacity for poly ...

Read more
ICP acquires leading supplier of dry erase coatings IdeaPaint

ANDOVER, US: Innovative Chemical Products (ICP Group) today has acquired IdeaPaint, creators and world-recognized leaders of the high-performance dry ...

Read more
Biesterfeld acquires distribution rights from DuPont for Selar polyamide

HAMBURG, GERMANY: Biesterfeld will take over the distribution of DuPont's product Selar PA 3426R from the 1 October 2019. This new agreement applies t ...

Read more
Henkel invests in US cleaning startup Truman with sustainability focus

DUSSELDORF, GERMANY: Henkel AG under the umbrella of Henkel Ventures is investing in the US cleaning products start-up Truman’s, based in L ...

Read more
India nitrocellulose market to exceed $61 million by 2024: Report

The India nitrocellulose market size is estimated to exceed USD 61 million by 2024, according to the new report by Graphical Research. The report is ...

Read more
McDermott bags module fabrication contract for Arctic LNG project

HOUSTON, US: McDermott International Inc said that its joint venture Qingdao McDermott Wuchuan Offshore Engineering Co Ltd (QMW) in Qingdao, China, ha ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X